For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative firsts, Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, urology and nephrology. With the same unwavering passion for new challenges, we dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.  Rooted in rich scientific collaborations and community-based relationships, we have access to some of the top minds in science today, allowing us to advance the treatment of patients through our innovative medicines. Our discoveries lead us not only to new treatments, but also to new ways to empower patients and expand their access to quality care.  

www.advocacyconnector.com

Patient Assistance Program

Cancer.com: Providing clarity in your search for cancer resources

We help take the guesswork out of your search by carefully selecting information and resources from respected sources and bringing them to you. Cancer.com is not intended to provide medical advice, so you should always talk with your treatment team about any medical decisions and concerns you may have.

Let us know what you need so we can help connect you with the information and support that you’re looking for.

Janssen CarePathGeneral Resources https://www.janssencarepath.com/hcp/general-resources

Access support to help navigate payer processes

Know Your State Interactive Tool — Provides information on affordability options for your patients at the state level.

Supporting Appropriate Payer Coverage Decisions Brochure — Helps you understand the information that payers may require for your patient’s coverage of medically necessary drug therapies.

Prior Authorization Considerations Checklist — Presents general information on prior authorization processes, including items and information that may be requested from your patient’s insurer.

Exception Considerations Checklist — Gives an overview of exception processes for your patient’s coverage of medically necessary drug therapies.

Appeal Considerations Checklist — Provides general information on insurance appeals processes, which can be useful if your patient’s insurer denies coverage.

Affordability support to help your patients start and stay on the treatment you prescribe

Affordability Options for Prescription Drugs Summary — Presents resources that may assist patients with their prescription drug costs based on their primary insurance status.

2020 Medicare Open Enrollment Resources for Patients — Key dates and online resources

• Part C (Medicare Advantage) and Part D (prescription drug coverage)
• Medigap — Medicare Supplemental Insurance
• Health Insurance Marketplace

Medicare Resource Guide — Provides important information for your patients to consider when selecting their insurance coverage.

Part B vs D Brochure — Outlines Medicare coverage under Parts B and D and illustrates the impact on patients who incur costs for branded medications.

Medicare Part D and the “Donut Hole” Resource for Patients — Explains the 4 phases of coverage and how patient out-of-pocket costs may change throughout the year.

Medicare Low-Income Subsidy (LIS) Brochure — Offers information about extra help with prescription drug costs that is available to low–income residents of the United States enrolled in Medicare Prescription Drug Plans.

Medicare Low-Income Subsidy (LIS) “Extra Help” Resource for Patients — Explains the level of “Extra Help” for low-income residents of the United States enrolled in Medicare Prescription Drug plans, the qualifications for each level, and how patients can apply.

Other Resources — Link to Web site for Johnson & Johnson Patient Assistance Foundation (JJPAF) – an independent, nonprofit organization committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.

Treatment support to help your patients get informed and stay on prescribed Janssen treatment

See product-specific resources on the Janssen medication pages on this Web site.